Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Esteve

Showing results (261-270 of 285) with videos related to

Pageof 29
Sort By:
Leukemia|December 19, 2008
CTLA-4 genotype and relapse incidence in patients with acute myeloid leukemia in first complete remission after induction chemotherapyA Pérez-García, S Brunet, J J Berlanga, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 1, 1996
Comparison of the diagnostic and prognostic value of biological markers in neuroblastoma. Proposal for a common methodology of analysis. SENSE groupM C Favrot, P Ambros, F Schilling, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 11, 2018
Current time-to-positivity of blood cultures in febrile neutropenia: a tool to be used in stewardship de-escalation strategiesP Puerta-Alcalde, C Cardozo, M Suárez-Lledó, et al.
Nature Communications|September 5, 2015
Nanoscale imaging of buried topological defects with quantitative X-ray magnetic microscopyC Blanco-Roldán, C Quirós, A Sorrentino, et al.
Bone Marrow Transplantation|April 19, 2016
Autologous transplant remains the preferred therapy for relapsed APL in CR2C Ganzel, V Mathews, K Alimoghaddam, et al.
Leukemia|September 28, 2013
MicroRNA expression at diagnosis adds relevant prognostic information to molecular categorization in patients with intermediate-risk cytogenetic acute myeloid leukemiaM Díaz-Beyá, S Brunet, J Nomdedéu, et al.
Annals of Hematology|February 17, 2020
Application of a digital PCR method for WT1 to myeloid neoplasms in CR and deep ELN WT1 molecular response (< 10 copies)E Bussaglia, M Pratcorona, M Carricondo, et al.
Leukemia|January 6, 2007
Outcome of patients with acute promyelocytic leukemia failing to front-line treatment with all-trans retinoic acid and anthracycline-based chemotherapy (PETHEMA protocols LPA96 and LPA99): benefit of an early interventionJ Esteve, L Escoda, G Martín, et al.
Leukemia|November 28, 2006
HLA-identical sibling allogeneic peripheral blood stem cell transplantation with reduced intensity conditioning compared to autologous peripheral blood stem cell transplantation for elderly patients with de novo acute myeloid leukemiaA-L Herr, M Labopin, D Blaise, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 31, 2003
Therapy-related acute promyelocytic leukemiaM Beaumont, M Sanz, P M Carli, et al.
Pageof 29

Showing results (261-270 of 285) with videos related to

Sort By:
Pageof 29
Leukemia|December 19, 2008
CTLA-4 genotype and relapse incidence in patients with acute myeloid leukemia in first complete remission after induction chemotherapyA Pérez-García, S Brunet, J J Berlanga, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 1, 1996
Comparison of the diagnostic and prognostic value of biological markers in neuroblastoma. Proposal for a common methodology of analysis. SENSE groupM C Favrot, P Ambros, F Schilling, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 11, 2018
Current time-to-positivity of blood cultures in febrile neutropenia: a tool to be used in stewardship de-escalation strategiesP Puerta-Alcalde, C Cardozo, M Suárez-Lledó, et al.
Nature Communications|September 5, 2015
Nanoscale imaging of buried topological defects with quantitative X-ray magnetic microscopyC Blanco-Roldán, C Quirós, A Sorrentino, et al.
Bone Marrow Transplantation|April 19, 2016
Autologous transplant remains the preferred therapy for relapsed APL in CR2C Ganzel, V Mathews, K Alimoghaddam, et al.
Leukemia|September 28, 2013
MicroRNA expression at diagnosis adds relevant prognostic information to molecular categorization in patients with intermediate-risk cytogenetic acute myeloid leukemiaM Díaz-Beyá, S Brunet, J Nomdedéu, et al.
Annals of Hematology|February 17, 2020
Application of a digital PCR method for WT1 to myeloid neoplasms in CR and deep ELN WT1 molecular response (< 10 copies)E Bussaglia, M Pratcorona, M Carricondo, et al.
Leukemia|January 6, 2007
Outcome of patients with acute promyelocytic leukemia failing to front-line treatment with all-trans retinoic acid and anthracycline-based chemotherapy (PETHEMA protocols LPA96 and LPA99): benefit of an early interventionJ Esteve, L Escoda, G Martín, et al.
Leukemia|November 28, 2006
HLA-identical sibling allogeneic peripheral blood stem cell transplantation with reduced intensity conditioning compared to autologous peripheral blood stem cell transplantation for elderly patients with de novo acute myeloid leukemiaA-L Herr, M Labopin, D Blaise, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 31, 2003
Therapy-related acute promyelocytic leukemiaM Beaumont, M Sanz, P M Carli, et al.
Pageof 29